# Career Re-Entry — Wave 1 Synthesis & Recommendation

> Synthesized by coordinator from W1 (market/path), W2 (transferable/adjacent), W3 (WLB/rhythm), W4 (geography/transit). Full worker outputs in `./findings/`.

## The one-line answer
**Commit to Regulatory Operations → Regulatory Affairs (IC track); lead with her existing hands-on Veeva experience and pick up eCTD/submission-publishing exposure.** It's the one path all four workers converge on, and it clears every one of her hard constraints.

> **CORRECTION (W5, supersedes earlier drafts + the shared report):** The earlier "do the $300 Veeva Vault Platform *Administrator* cert regardless of lane" advice was WRONG for her. That cert is aimed at system-*administrator* roles, not her Reg Ops/clinical lane; it is **$300 that expires yearly + a recurring maintenance fee** (not a clean one-off); and for her lane **hands-on Veeva experience >> the admin cert**. Only pursue it if she deliberately chooses the Vault-Admin/BSA branch. See "The credential reality" below.

## Why this is the answer (where the four workers agree)
- **It's the only function where her existing skills ARE the job, not adjacent to it.** Veeva Vault Author-level + doc control + TMF + GxP + (per résumé) *already routing IP labels with Regulatory Affairs* = ~70% qualified on day one. Everywhere else she's transferring in. (W1)
- **Her Veeva skill is the crown jewel, and 2026 made it scarce.** FDA **QMSR took effect Feb 2 2026** (incorporates ISO 13485 by reference) and the **CSV→CSA re-skill wave** (83% of practitioners need retraining) means the whole industry is re-skilling *at the same time* — which structurally shrinks her 2.5-yr gap from "deficit" to "everyone's refreshing anyway." (W2)
- **It resolves her core internal tension.** Her energizers ("get it to market," "the why / what we observed") point at Data Management & Medical Writing — but those are **high-isolation solo roles, her #1 thing to avoid.** Regulatory Affairs keeps the commercialization/"why" satisfaction *while staying collaborative* (it's the cross-functional "air-traffic-control" bridge). (W3)
- **Geography stops being a blocker.** Reg Ops/Publishing is both fully remote-capable AND her most natural bridge from Doc Control — so the no-car constraint dissolves. If she prefers an office, Bay Area is workable car-free via free public shuttles (Palo Alto ~45m, Mission Bay/Emeryville ~60m). (W4)
- **The IC ladder reaches her $150k goal with nobody reporting to her:** RA Specialist → Sr → **Principal RA Specialist $133–177k**. **RAC-certification-eligible today** via her QA years. (W1)

## The myth we busted
The candidate believes "audit/deadline crunch is unavoidable in pharma." **It's not** — it's cyclical/schedulable, and the audit-scramble she specifically fears is the *most avoidable* kind ("compliance by design" vs "compliance by crisis"). **Her bad WLB experience was driven by company STAGE (lean startups) more than function.** Target mid/large pharma or a big CRO and the spikes get buffered by a deep bench. (W3)

## ClinOps verdict (the original assumption)
**Beaten — do not default to it.** Entry Clinical Trial Assistant ($50–72k) is *below her floor*; the $150k ladder runs through field CRA, which her no-driving constraint **disqualifies** (50–75% travel). Study Start-Up Specialist is the one ClinOps role worth keeping as a possible bridge. (W1, W3, W4)

## The three viable lanes (all clear her constraints; they trade differently)
| Lane | Best at | Cost | Ceiling | Isolation |
|---|---|---|---|---|
| **A. Regulatory Ops → Affairs** ⭐ | Skills-match, balance, resolves tension | eCTD/RIM exposure now; RAC in-role (12–24mo) | $150–177k IC | Low |
| **B. Quality Systems / Process-Improvement (+ CSV/CSA)** | Her **#1 energizer** (process improvement); **highest ceiling** | Six Sigma / GAMP5-CSA (~$2.9k, 10wk) | $150–190k IC | Low–Med |
| **C. Clinical Supply via remote CRO** | **Fastest/safest** re-entry — near-verbatim résumé match | ~none | Lower (needs a light-mgmt rung for $150k) | Low |

## The credential reality (W5 fact-check — supersedes W2's cert framing)
- **RAC (RAPS Regulatory Affairs Certification):** She IS eligible now — RAPS explicitly counts QA/QC + clinical-research experience, and she clears the BS + 3-yr bar several times over. BUT it costs **$605 member / $760 non-member** (not ~$500), 120q/2.5hr, ~3–6mo prep, track = **RAC-Drugs**, and it is a **mid-career accelerator, "preferred" not "required"** at associate level. **She does NOT need it to get in.** Sequence: land an associate Reg Ops role on her QA/clinical-supply credibility → earn RAC-Drugs in the first 12–24 months (often employer-funded) as the lever toward the $150k ladder. For *entry*, eCTD/submission-publishing skills matter more than RAC.
- **Veeva Vault Platform Administrator cert (~$300/yr recurring):** Mostly resume-decoration / mis-targeted for her Reg Ops/clinical lane. Genuinely valued only for **dedicated Vault Administrator / Business-Systems-Analyst** roles (a different, legitimate IC branch). For her chosen lane: **skip the cert; foreground hands-on Veeva experience** and add low-cost eCTD/RIM exposure instead.
- **The actual cheap, high-ROI move:** hands-on **eCTD / submission-publishing / Vault RIM** familiarity (short course or on-the-job), which is what entry Reg Ops postings actually screen for.

## Open follow-up (decision-grade, for Wave 2)
Forum sentiment (Reddit/Blind/Glassdoor) for *named target employers* was crawler-blocked this run. Before she signs anywhere, do a browser-based WLB pull on the specific shortlisted employers (esp. CROs — IQVIA/Syneos ~3.8/5; avoid Medpace on WLB). (W3)

## Recommended next step
Confirm the lane (recommend **A, with eCTD/submission-publishing exposure as step 1**), then spawn Wave 2: (W5) upskilling ROI for the chosen lane, (W6) resume + LinkedIn rebuild with the honest gap framing, (W7) LLM-era job-hunt playbook (CRO staffing agencies, contract-to-hire on-ramp, networking, interview prep).